Teresa DeLuca, M.D., is leaving the board of directors at LifeStance Health Group, Inc. She notified the company's board on October 14, 2026, that she will resign from the board and all of its committees. Her departure takes effect on December 31, 2026.
The company stated that Dr. DeLuca's resignation is not the result of any disagreement between her and LifeStance Health Group. The filing was submitted to the U.S. Securities and Exchange Commission on October 16, 2026.
LifeStance Health Group is a Delaware corporation headquartered in Scottsdale, Arizona. Its common stock trades on the Nasdaq Global Select Market under the ticker symbol LFST. The company's principal executive offices are located at 4800 N. Scottsdale Road, Suite 2500, Scottsdale, Arizona 85251.
The Form 8-K filing was signed by Ryan Pardo, who serves as the Chief Legal Officer and Secretary for LifeStance Health Group. The report indicates that Dr. DeLuca's exit is a voluntary resignation from all board roles effective at the end of the year.